Absence of response to human parathyroid hormone in athymic mice grafted with human parathyroid adenoma, hyperplasia or parathyroid cells maintained in culture

Journal of Endocrinological Investigation

Volumn 23, Issue 5, 2000, Pages 273-279

  Hory, B G ^a,b   Roussanne, M C ^a   Rostand, S ^a   Bourdeau, A ^a   Drueke T B ^a   Gogusev, J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE   (France)

Author keywords

Culture; Human parathyroid cells; Hypercalcemia; Hyperparathyroidism; Interleukin 1; Interleukin 6; Parathyroid xenotransplantation

Indexed keywords

CALCIUM; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; PARATHYROID HORMONE; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE TURNOVER; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNE RESPONSE; MOUSE; NONHUMAN; PARATHYROID CELL; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; T LYMPHOCYTE; XENOTRANSPLANTATION;

EID: 0033919447     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343723     Document Type: Article

References (40)

1. Jaeger P., Jones W., Kashgarian M., Baron R., Clemens T., Segre G., Hayslett J. Animal model of hyperparathyroidism. Am. J. Physiol. 1987, 252: E790-E798.
2. Gittes R., Radde I. Experimental hyperparathyroidism from multiple isologous parathyroid transplants: homeostatic effect of simultaneous thyroid transplant. Endocrinology 1966, 78: 1015-1022.
3. Tanaka Y., Funahashi H., Imai T., Tobinaga J., Murase H., Andoh H., Wada M., Matsuyama T., Tominaga Y., Takagi H. Heterotransplantation of human parathyroid glands into nude mice. Endocr. J. 1995, 42: 9-14.
4. Schachter P., Buckley N., Oyama H., Christy M., Leight G., Lobaugh B., Durham N. Primary hyperparathyroidism: a new experimental model. Surgery 1989, 106: 997-1001.
5. Schachter P., Christy M.D., Leight G.S., Lobaugh B. Function in athymic nude mice of parathyroid heterografts from patients with primary hyperparathyroidism and secondary hyperparathyroidism. Surgery 1990, 108: 1040-1046.
6. Lewin E., Wang W., Olgaard K. Reversibility of experimental secondary hyperparathyroidism. Kidney Int. 1997, 52: 1232-1241.
7. 2+-sensing receptor expression in functionally active long term human parathyroid cell cultures. J. Bone Miner. Res. 1998, 13: 354-362.
8. Nussbaum S.R., Zahradnick R.J., Lavigne J.R., Brennan G.L., Nozawa-Ung K., Kim L.Y., Keutmann H.T., Wang C., Potts J.T. Jr., Segre G.V. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem. 1987, 33: 1364-1367.
9. Anonymous. Guide for the Care and Use of Laboratory Animals. McGraw-Hill, Washington, DC, 1996, p. 170.
10. Beaudreuil J., Mbalaviele G., Solal M.C., Morieux C., de Vernejoul M.C., Orcel P. Short-term local injections of transforming growth factors-β1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats. J. Bone Miner. Res. 1995, 10: 971-977.
11. Orcel P., Feuga M., Bielakoff J., de Vernejoul M.C. Local bone injections of lipopolysaccharide and of macrophage-stimulating factor increase bone resorption by different pathways in vivo in normal rats. Am. J. Physiol. 1993, 264: E391-E397.
12. Parfitt A., Dresner M., Glorieux F., Kanis J., Malluche H., Meunier J., Ott S., Recker R. Bone histomorphometry: standardization of nomenclature, symbols, and unit. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 1987, 2: 595-610.
13. 2+ and other ions as extracellular (first) messengers. Physiol. Rev. 1991, 71: 371-411.
14. Zahrani A., Levine M. Primary hyperparathyroidism. Lancet 1997, 349: 1233-1238.
15. Brown E., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hedlger M., Lytton J., Hebert S. Cloning and characterization of an extracellular calcium sensing receptor from bovine parathyroid. Nature 1993, 366: 575-580.
16. Almaden Y., Hernandez A., Torregrosa V., Canalejo A., Sabate P., Campistol J.M., Torres A., Rodriguez M. High phosphate level directly stimulates parathyroid secretion and parathyroid synthesis by human parathyroid tissue in vitro. J. Am. Soc. Nephrol. 1998, 9: 1845-1852.
17. Slatopolsky E., Finch J., Denda M., Ritter C., Zhong M., Dusso A., McDonald P., Brown A. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J. Clin. Invest. 1996, 97: 2534-2540.
18. Ander S.J.O., Blomkvist L.M., Smeds S.P.I., Johansson K.J.M., Molne J.C. Revascularisation of human parathyroid tissue transplanted to athymic mice. APMIS 1997, 105: 931-940.
19. Gröne A., McCauley L., Capen C., Rosol T. Parathyroid hormone/parathyroid hormone-related protein receptor expression in nude mice with a transplantable canine apocrine adenocarcinoma (CAC-8) and humoral hypercalcemia of malignancy. J. Endocrinol. 1997, 153: 123-129.
20. Rosol T., Capen C., Horst R. Effects of infusion of human parathyroid hormone-related protein (1-40) in nude mice: histomorphometric and biochemical investigations. J. Bone. Miner. Res. 1988, 3: 699-706.
21. Kong X., Shipani E., Lanske B., Joun H., Karperian M., Defize L., Juppner H., Potts J., Segre G., Kronenberg H., Abou-Samra A. The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone related peptide are highly homologous. Biochem. Biophys. Res. Comm. 1994, 200: 1290-1299.
22. Karpf D., Arnaud C., King K., Bambino T., Winer J., Nyiredy K., Nissensson R. The canine renal parathyroid hormone receptor is a glycoprotein: characterization and partial purification. Biochemistry 1987, 26: 7835-7833.
23. Shigeno C., Hirahi Y., Westerberg D., Potts J., Segre G. Parathyroid hormone receptors are plasma membrane glycoproteins with asparaginase-linked oligosaccharides. J. Biol. Chem. 1988, 263: 3872-3878.
24. Obie J., Cooper C. Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Azlet osmotic pump. J. Pharmacol. Exp. Ther. 1979, 209: 422-428.
25. deVernejoul M.C., Cohen-Solal M.E., Orcel P. Bone cytokines. Curr. Opinion. Rheumatol. 1993, 5: 332-338.
26. Lee S., Lorenzo J. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999, 140: 3552-3561.
27. Van Bezooijen R., Farih-Slips H., Papapoulos S., Lowik C. Interleukin-17: a new bone acting cytokine in vitro. J. Bone Miner. Res. 1999, 14: 1513-1521.
28. Grey A., Mitnick M., Shapses S., Ellison A., Gundberg C., Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption- A clinical research center study. J. Clin. Endocinol. Metab. 1996, 81: 3450-3454.
29. Dewhirst F., Ago J., Peros W., Stashenko P. Synergism between parathyroid hormone and interleukin-1 in stimulating bone resorption in organe culture. J. Bone. Miner. Res. 1987, 34: 127-134.
30. Langub M.C., Nicholas J.R., Koszewski J., Turner H., Faugere M.C.M., Geng Z., Malluche H. Bone resorption and mRNA expression of IL-6 and IL-6 receptor in renal osteodystrophy. Kidney Int. 1996, 50: 515-520.
31. de la Mata J., Uy H.L., Guise T.A., Story B., Boyce B.F., Mundy G.R., Roodman G.D. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 1995, 95: 2846-2852.
32. Weissglas M., Schamhart D., Lowik C., Papapoulos S., Theuns H., Kurth K. The role of interleukin-6 in the induction of hypercalcemia in renal cell carcinoma transplanted into nude mice. Endocrinology 1997, 138: 1879-1885.
33. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G., Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994, 13: 1189-1196.
34. Mc Cauley L., Rosol T., Capen C., Horton J., Shanfeld J. Investigations on in vitro bone resorbing activity from athymic (nude) and euthymic mouse splenic leukocytes. Bone 1989, 10: 389-394.
35. Mc Cauley L., Rosol T., Capen C., Horton J. A comparaison of bone turnover in athymic (nude) and euthymic mice: biochemical, histomorphometric, bone ash and in vitro studies. Bone 1989, 10: 29-34.
36. Grabbe S., Gallo R., Lindgren A., Granstein R. Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. Restoration with thymic transplantation or administration of cytokines. J. Immunol. 1993, 151: 3430-3439.
37. Horowitz M., Vignery A., Gershon R., Baron R. Thymus derived lymphocytes and their interaction with macrophages are required for the production of osteclast-activating factors in the mouse. Proc. Natl. Acad. Sci. USA 1984, 81: 2181-2185.
38. Bushinsky F., Ma Y., Mann G., Rucinski B., Bryer H., Romero D., Jee W., Epstein S. T lymphocytes play a critical role in the development of Cyclosporin A-induced osteopenia. Endocrinology 1996, 137: 2278-2285.
39. Dumoulin G., Hory B.G., Nguyen N.U., Henriet M.T., Bresson C., Regnard J., Saint-Hillier Y. Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients. Transplantation 1995, 59: 1690-4.
40. Abraham M., Balint E., Marshall C., Stem P., Sprague S. Interleukin-6 release and bone resorption in T cell deficient mice. Amer. Soc. Nephrol. San Antonio 1997: 8547A.